Pharmacopuncture Therapy as an Adjunctive Treatment for Patients with Lumbar Spinal Stenosis: A Pragmatic Randomized Controlled Pilot Trial.

If you've ever been told you have lumbar spinal stenosis (LSS) — a narrowing of the spinal canal that causes back, buttock, and leg pain — you know how much it can limit everyday life, including something as simple as walking. Researchers in Korea recently looked at whether adding a treatment called pharmacopuncture to standard care could help people with this condition feel better faster.

Pharmopuncture is a technique that combines traditional acupuncture with the injection of small amounts of herbal or medicinal extracts directly into acupuncture points. In this study, 40 patients with LSS were split into two groups. One group received standard Korean medicine treatments — including electroacupuncture, cupping, and infrared therapy — while the other group received all of those same treatments plus pharmacopuncture. Both groups completed 10 treatment sessions over five weeks.

The main goal was to measure changes in buttock and leg pain using a simple 0–100 pain scale. While the difference between the two groups on that specific measure didn't reach statistical significance, the pharmacopuncture group did show notably greater reductions in low back pain and were more likely to reach a meaningful level of improvement overall. The add-on treatment was also found to be safe and well-tolerated. One patient experienced a mild skin rash that cleared up the same day — no serious side effects were reported.

For patients exploring options beyond standard care, these results are encouraging. Pharmacopuncture appears to be a safe and potentially helpful addition to conventional treatment for spinal stenosis, though larger studies are still needed to confirm its full benefits.

If you're interested in exploring pharmacopuncture or acupuncture for back pain, speak with a licensed acupuncturist or integrative medicine provider who has experience treating spinal conditions.

This pragmatic randomized controlled pilot trial evaluated the feasibility and safety of pharmacopuncture therapy (PPT) as an adjunct to conventional Korean medicine treatment (CKMT — electroacupuncture, cupping, infrared) in 40 patients diagnosed with lumbar spinal stenosis (LSS), randomized 1:1 over 10 sessions across five weeks. The primary outcome (100-mm VAS for buttock/leg pain at week 5) did not reach statistical significance between groups (adjusted mean difference: 8.0; 95% CI: −1.4 to 17.4). However, the PPT group demonstrated a clinically meaningful advantage in low back pain VAS at week 5 (adjusted mean difference: 12.9; 95% CI: 2.4–23.4) and a higher proportion achieving minimum clinically important difference. Completion rates were high (95% vs. 100%). One adverse event — a transient systemic skin rash — was reported in the PPT group. The trial establishes feasibility and an acceptable safety profile for add-on PPT in LSS management, warranting a fully powered confirmatory RCT.